Aurobindo Pharma informs about board meeting

31 Jul 2024 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Saturday, August 10, 2024, to consider and approve the Standalone & Consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2024. Further to its letter dated June 26, 2024, informing the closure of Trading Window of the Company from July 1, 2024, until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the first quarter ended June 30, 2024, the Trading Window will remain closed up to August 12, 2024, and shall be reopened on August 13, 2024.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.